title: Impaired ovarian function and risk factors for atherosclerosis in premenopausal women.
abstract: OBJECTIVE
  The aim of the study was to obtain information on the possible relationship between impaired ovarian function and risk factors for cardiovascular disease.
  
  
  METHODS
  Serum lipid levels, plasma fibrinolytic potential and histological and biochemical changes in the intima of the uterine artery were investigated in premenopausal women with irregular menstrual cycles, and the results were compared with those from regularly menstruating women. In addition, the same parameters were studied in postmenopausal women on hormone replacement therapy (HRT) and in postmenopausal women who had never used HRT. In total 64 patients undergoing hysterectomy for benign reasons were included the study.
  
  
  RESULTS
  Plasma fibrinogen concentration was significantly higher in irregularly menstruating women as compared with women with regular cycles. In women with irregular cycles thickened or sclerotic arterial intima was a significantly more common finding as compared with regularly menstruating women. A significant positive correlation was observed between plasma fibrinogen concentration and intimal esterified cholesterol content in women with thickened or sclerotic uterine artery.
  
  
  CONCLUSIONS
  These data suggest an important role for normal ovarian function in the prevention of atherosclerosis.
authors.affiliation: Department of Obstetrics and Gynecology, University Hospital of Tampere, Finland.
authors.forename: R
authors.initials: R
authors.lastname: Punnonen
authors.forename: H
authors.initials: H
authors.lastname: Jokela
authors.forename: R
authors.initials: R
authors.lastname: Aine
authors.forename: K
authors.initials: K
authors.lastname: Teisala
authors.forename: A
authors.initials: A
authors.lastname: Salomäki
authors.forename: H
authors.initials: H
authors.lastname: Uppa
mesh_terms: D000328:Adult; D001161:Arteriosclerosis / Q000209:etiology* / Q000503:physiopathology / Q000517:prevention & control; D002788:Cholesterol Esters / Q000097:blood; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D015914:Estrogen Replacement Therapy; D005260:Female; D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D007044:Hysterectomy; D008055:Lipids / Q000097:blood; D008875:Middle Aged; D010050:Ovarian Function Tests; D017697:Premenopause / Q000187:drug effects / Q000502:physiology; D017539:Tunica Intima / Q000473:pathology; D014599:Uterus / Q000098:blood supply
chemical_list: D002788:Cholesterol Esters; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D008055:Lipids; D005340:Fibrinogen